MSD Animal Health receives European marketing authorization for Innovax-ND-H5 vaccine for use in chickens

Source :: PharmaBiz. May 27, 2024
Publication Year :: 2024
Abstract: MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA announced that the European Commission has granted the marketing authorization for the Innovax-ND-H5 vaccine for chickens. This [...]

Subjects :: Merck & Company Inc.
Avian influenza -- Health aspects
Influenza vaccines -- Health aspects
Poultry industry -- Health aspects
Drug approval -- Health aspects
Marketing -- Health aspects
Viral proteins -- Health aspects
Pharmaceutical industry -- Health aspects
Pharmaceuticals and cosmetics industries
European Union. European Commission

Tools